[go: up one dir, main page]

DK141050B - Analogifremgangsmåde til fremstilling af svovlholdige pyridinderivater. - Google Patents

Analogifremgangsmåde til fremstilling af svovlholdige pyridinderivater.

Info

Publication number
DK141050B
DK141050B DK642669AA DK642669A DK141050B DK 141050 B DK141050 B DK 141050B DK 642669A A DK642669A A DK 642669AA DK 642669 A DK642669 A DK 642669A DK 141050 B DK141050 B DK 141050B
Authority
DK
Denmark
Prior art keywords
sulfur
preparation
pyridine derivatives
analogous process
containing pyridine
Prior art date
Application number
DK642669AA
Other languages
English (en)
Other versions
DK141050C (da
Inventor
Gustav Schorre
Herbert Nowak
Otto Saiko
Original Assignee
Merck Ag E
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Ag E filed Critical Merck Ag E
Publication of DK141050B publication Critical patent/DK141050B/da
Application granted granted Critical
Publication of DK141050C publication Critical patent/DK141050C/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62Oxygen or sulfur atoms
    • C07D213/63One oxygen atom
    • C07D213/65One oxygen atom attached in position 3 or 5
    • C07D213/66One oxygen atom attached in position 3 or 5 having in position 3 an oxygen atom and in each of the positions 4 and 5 a carbon atom bound to an oxygen, sulphur, or nitrogen atom, e.g. pyridoxal
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/06Antigout agents, e.g. antihyperuricemic or uricosuric agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D491/00Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04Ortho-condensed systems
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Neurology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Biomedical Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurosurgery (AREA)
  • General Health & Medical Sciences (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pyridine Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DK642669AA 1968-12-05 1969-12-04 Analogifremgangsmåde til fremstilling af svovlholdige pyridinderivater. DK141050B (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE1812794A DE1812794C3 (de) 1968-12-05 1968-12-05 2-Methyl-3-hydroxy-5-methylthiomethylpyridinderivate und Verfahren zu deren Herstellung

Publications (2)

Publication Number Publication Date
DK141050B true DK141050B (da) 1979-12-31
DK141050C DK141050C (da) 1980-06-16

Family

ID=5715283

Family Applications (1)

Application Number Title Priority Date Filing Date
DK642669AA DK141050B (da) 1968-12-05 1969-12-04 Analogifremgangsmåde til fremstilling af svovlholdige pyridinderivater.

Country Status (16)

Country Link
US (2) US3658825A (da)
JP (1) JPS5243834B1 (da)
AT (4) AT309430B (da)
BE (1) BE742641A (da)
BR (1) BR6914813D0 (da)
CH (4) CH545291A (da)
CS (3) CS164837B2 (da)
DE (1) DE1812794C3 (da)
DK (1) DK141050B (da)
ES (1) ES374266A1 (da)
FR (1) FR2025454A1 (da)
GB (1) GB1263370A (da)
IL (1) IL33437A (da)
IT (1) IT7947631A0 (da)
NL (1) NL167421C (da)
SE (1) SE366310B (da)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5336441A (en) * 1991-05-29 1994-08-09 Petrolite Corporation Corrosion inhibition in highly acidic environments by use of pyridine salts in combination with certain cationic surfactants

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1220422B (de) * 1963-09-07 1966-07-07 Merck Ag E Verfahren zur Herstellung eines neuen Bis-pyridyl-methyl-disulfids
US3525749A (en) * 1969-03-19 1970-08-25 Merck & Co Inc Certain 1,3-dioxepino-(5,6-c)-pyridines

Also Published As

Publication number Publication date
CH562797A5 (de) 1975-06-13
CS164837B2 (da) 1975-11-28
FR2025454B1 (da) 1974-05-24
ES374266A1 (es) 1972-03-16
AT311970B (de) 1973-12-10
CH544756A (de) 1973-11-30
GB1263370A (en) 1972-02-09
US3759930A (en) 1973-09-18
DK141050C (da) 1980-06-16
US3658825A (en) 1972-04-25
DE1812794C3 (de) 1978-10-05
BR6914813D0 (pt) 1973-03-08
AT309427B (de) 1973-08-27
DE1812794A1 (de) 1970-07-02
IL33437A0 (en) 1970-01-29
AT309430B (de) 1973-08-27
IL33437A (en) 1973-03-30
CH545291A (de) 1974-01-31
NL6918252A (nl) 1970-06-09
JPS5243834B1 (da) 1977-11-02
SE366310B (sv) 1974-04-22
CH544757A (de) 1974-01-15
DE1812794B2 (de) 1978-02-02
NL167421C (nl) 1981-12-16
AT311347B (de) 1973-11-12
BE742641A (fr) 1970-06-04
CS164836B2 (da) 1975-11-28
CS164838B2 (da) 1975-11-28
FR2025454A1 (fr) 1970-09-11
NL167421B (nl) 1981-07-16
IT7947631A0 (it) 1979-01-15

Similar Documents

Publication Publication Date Title
DK126193B (da) Analogifremgangsmåde til fremstilling af derivater af substitueret N-amino-indolin.
DK122964B (da) Fremgangsmåde til fremstilling af 3-amino-4-iod-5-methylisoxazolderivater.
DK131628B (da) Fremgangsmåde til fremstilling af tioninderivater.
DK122965B (da) Analogifremgangsmåde til fremstilling af derivater af thiazolylbenzoesyre.
DK126994B (da) Analogifremgangsmåde til fremstilling af aminopyridinderivater.
DK124207B (da) Fremgangsmåde til fremstilling af isothiazolderivater.
DK125091B (da) Fremgangsmåde til fremstilling af 1-hydroxy-2-pyridoner.
DK125326B (da) Analogifremgangsmåde til fremstilling af phenylthiazol-2-ylmalonsyrederivater.
DK125089B (da) Analogifremgangsmåde til fremstilling af evomonosidderivater.
DK126944B (da) Analogifremgangsmåde til fremstilling af hexahydrobenzindolderivater.
DK125852B (da) Fremgangsmåde til fremstilling af erythromycylamin.
DK123471B (da) Analogifremgangsmåde til fremstilling af benzyliden-amino-oxyalkylcarboxylsyrederivater.
DK133430B (da) Analogifremgangsmåde til fremstilling af 1-carbamoyl-3-aroylpyrrolidiner.
DK122124B (da) Fremgangsmåde til fremstilling af 2-acyloxythionobenzamider.
DK123300B (da) Analogifremgangsmåde til fremstilling af thiophen-3-isonitriler.
DK131863B (da) Analogifremgangsmåde til fremstilling af thiazolino- eller thiazidino-pyrimidinderivater.
DK128778B (da) Analogifremgangsmåde til fremstilling af bis-2-carboxy-chromonylderivater.
DK120292B (da) Analogifremgangsmåde til fremstilling af 2-aryloksymetylpiperazinderivater.
DK125464C (da) Analogifremgangsmåde til fremstilling af 6-halogen-15β, 16β-methylen-pregnanderivater.
DK128008B (da) Fremgangsmåde til fremstilling af 1-glykosyl-5-azacytosiner.
DK129282B (da) Fremgangsmåde til fremstilling af indanderivater.
DK136982B (da) Fremgangsmåde til fremstilling af quinolinderivater.
DK125592B (da) Analogifremgangsmåde til fremstilling af derivater af nicotinursyre.
DK123096B (da) Analogifremgangsmåde til fremstilling af neriifolinderivater.
DK128680B (da) Analogifremgangsmåde til fremstilling af phenazinderivater.

Legal Events

Date Code Title Description
PBP Patent lapsed